vTv Therapeutics Inc. (VTVT) Financials
VTVT Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-12-31 | 11.0 million | 29.6 million |
2023-09-30 | 14.9 million | 29.4 million |
2023-06-30 | 22.4 million | 28.8 million |
2023-03-31 | 28.8 million | 48.0 million |
VTVT Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-12-31 | -2.9 million | 403000 |
2023-09-30 | -4.8 million | 433000 |
2023-06-30 | -6.2 million | 399000 |
2023-03-31 | -5.2 million | 343000 |
VTVT Net Income
No data available :(
VTVT Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-12-31 | 9.4 million | - | 338000 |
2023-09-30 | 8.2 million | - | 378000 |
2023-06-30 | 12.6 million | - | 417000 |
2023-03-31 | 18.8 million | - | 454000 |
VTVT Shares Outstanding
VTVT Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-12-31 | - | 2.1 million | 2.6 million | - |
2023-09-30 | - | 2.8 million | 2.5 million | - |
2023-06-30 | - | 4.7 million | 3.3 million | - |
2023-03-31 | - | 3.9 million | 3.5 million | - |
VTVT Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-12-31 | - | 23000 |
2023-09-30 | - | 22000 |
2023-06-30 | 9000 | 23000 |
2023-03-31 | - | 22000 |
VTVT
Price: $23.69
52 week price:
Earnings Per Share: -9.71 USD
P/E Ratio: -0.96
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 36900
Ebitda: -11.5 millionMarket Capitalization: 60.5 million